Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Farxiga (Dapagliflozin) Farxiga sales in 2022: $4.381 billion Company/Developer: AstraZeneca Date of first FDA approval: January 8, 2014 Indications Farxiga is FDA-approved for: Type 2 diabetes, reducing risk of heart failure, chronic kidney disease (regardless of diabetic status) Price of Farxiga: About $623 for a supply of 30 oral 10 mg tablets Why it did so well: Farxiga is a SGLT2 inhibitor used primarily for the treatment of type 2 diabetes
If you dont have diabetes and youre looking into prescription options for obesity treatment, you may want to consider Wegovy, Saxenda, or Contrave instead of Ozempic
Hers/Hims Pricing: Starting at $599/month for brand-name GLP-1s
Nausea remains the most common side effect, even with the B12 addition
A recent trial found that patients who receive rosiglitazone experience an earlier onset of heart failure, a higher risk of cardiovascular mortality, and a higher risk of hospitalization than patients in the control group who received glyburide
US$ 26.10
US$ 24.78
US$ 26.05
US$ 28.44
US$ 23.32
US$ 22.36
US$ 22.33
US$ 24.38
US$ 20.74
US$ 21.12
